Q
QNCX//CIK 0001662774
Quince Therapeutics, Inc.
Market Data
$31.31+$13.45 (+75.36%)
QNCX · Last trade
Prev Close
$17.86
Range (30d)
$17.85 – $34.57
Recent Filings
- 8-K202.7 KBQuince Therapeutics, Inc.Aug 17, 6:01 AM ET·0001193125-26-353141
- SCHEDULE 13G154.5 KBQuince Therapeutics, Inc.Aug 14, 9:20 PM ET·0001193125-26-352966
- SCHEDULE 13G/A11.0 KBQuince Therapeutics, Inc.Aug 14, 4:44 PM ET·0001104659-26-097291
- 10-Q16.9 MBQuince Therapeutics, Inc.Aug 14, 4:05 PM ET·0001193125-26-352201
- SCHEDULE 13G12.0 KBQuince Therapeutics, Inc.Aug 14, 2:05 PM ET·0001172661-26-003692
- 8-K209.9 KBQuince Therapeutics, Inc.Aug 14, 8:21 AM ET·0001193125-26-350568
- SCHEDULE 13G16.4 KBQuince Therapeutics, Inc.Aug 14, 6:07 AM ET·0001172661-26-003433
- SCHEDULE 13G80.8 KBQuince Therapeutics, Inc.Aug 4, 3:06 PM ET·0002050709-26-000021
- 8-K152.5 KBQuince Therapeutics, Inc.Jul 31, 4:50 PM ET·0001193125-26-328784
- 8-K/A2.5 MBQuince Therapeutics, Inc.Jul 30, 6:02 AM ET·0001193125-26-324786
Insiders
10- Benatti LucaDirector
- Boeding ChadCEO of Former 10% Owner
- Bray JuneDirector
- Detke Michael J.Chief Medical Officer
- Dominy Stephen S.Director, Chief Scientific Officer
- EPIQ Capital Group, LLCFormer 10% Owner
- Gafric KristenSVP, Legal & Administration
- Hannah BrendanCBO, COO & CCO
- Holsinger LeslieEVP, Preclinical Development
- Janhofer GuenterChief Scientific Officer
Tickers
Addresses
business
611 GATEWAY BLVD., SUITE 273
SOUTH SAN FRANCISCO, CA, 94080
mailing
611 GATEWAY BLVD., SUITE 273
SOUTH SAN FRANCISCO, CA, 94080
Former Names
- Cortexyme, Inc.2022-08-01